Skip to main content


Showing posts from February 20, 2022

Division of Disability and Rehabilitative Services Home-and Community-Based Services Spend Plan update

In July, the Indiana Family and Social Services Administration submitted its  proposed spending plan for implementation of Home-and Community-Based Services Enhanced Federal Medical Assistance Percentage   to the Centers for Medicare and Medicaid Services for approval. The opportunity for enhanced FMAP was a part of the American Rescue Plan Act and allows for an additional 10% federal match on Medicaid HCBS expenditures from April 1, 2021, through March 31, 2022. The additional resources must be expended by March 2024. Based on stakeholder feedback, FSSA prioritized the use of the dollars as follows:  Plan component                                                              Percent of total Stabilization (provider, workforce and caregiver) 20% Workforce (Support and expand the HCBS provider workforce)   25% Enhance HCBS (Includes Increasing competitive employment opportunities) 20% Build provider capacity (Increase access to services/promote self-direction) 30% Caregiver training and

Q&A: Cutting Through COVID Confusion

 From  National Institute for Health Care Management (NIHCM) Foundation More than  900,000 Americans  have died from COVID-19, and while new cases have declined in the past week, deaths increased. As the world continues to grapple with COVID-19,  questions  remain about the future of the virus and what  endemic means . Here’s the latest news on common concerns:  Q: When can children under five get vaccinated? A:  Infants as young as six months could be vaccinated in the  next few weeks , depending on the Food and Drug Administration’s (FDA) review of Pfizer-BioNTech’s application for authorization of the vaccine for this age group.  Q: What do we know about the new variant? A:  The emerging  BA.2 sub-variant  of omicron  has replaced  the original strain in many countries and is detected in  more than half of the states . BA.2 does not appear to cause greater  disease severity  but a study from Denmark found it to be  33% more likely  to infect others compared to BA.1. Q: How effective

Infant Formula Recall Information

Abbott press release is here:   Abbott Voluntarily Recalls Powder Formulas Manufactured at One Plant FDA advisory is here:   FDA Investigation of Cronobacter and Salmonella Complaints: Powdered Infant Formula (February 2022)  Do not use recalled Similac, Alimentum, or EleCare powdered infant formulas   On Feb. 17, 2022, Abbott Nutrition initiated a voluntary recall of certain powdered infant formulas, including Similac, Alimentum and EleCare. FDA  issued an advisory  to alert consumers to avoid purchasing or using recalled powdered infant formula produced in the Sturgis, MI facility.   The FDA, along with CDC and state and local partners, are investigating four consumer complaints of infant illness related to products from Abbott Nutrition’s Sturgis, MI facility received from 9/20/2021 to 1/11/2022. All of the cases are reported to have consumed powdered infant formula produced from Abbott Nutrition’s Sturgis, MI facility. These complaints include three reports of  Cronobacter sakazaki